Investors

Insider Transactions

Date Name Title Type Sorted Descending Shares Traded Price Range
Dec 17, 2012 yancopoulos george Officer Option Execute 10,369 109.29
Nov 30, 2011 yancopoulos george Officer Option Execute 200,000 28.01
Dec 16, 2008 yancopoulos george Officer Option Execute 100,000 7.41
Dec 3, 2009 yancopoulos george Officer Option Execute 100,000 8.77
Dec 16, 2014 yancopoulos george Officer Option Execute 3,264 30.63
Aug 27, 2014 yancopoulos george Officer Option Execute 5,720 314.31
Dec 19, 2013 yancopoulos george Officer Option Execute 4,705 21.25
Feb 11, 2014 yancopoulos george Officer Option Execute 189,463 9.49
Nov 26, 2013 baker charles a Director Disposition (Non Open Market) 590 n/a
May 18, 2010 brown michael s Director Disposition (Non Open Market) 4,476 28.40
Nov 2, 2009 brown michael s Director Disposition (Non Open Market) 12,000 n/a
Jul 31, 2014 brown michael s Director Disposition (Non Open Market) 2,700 n/a
Jul 30, 2014 brown michael s Director Disposition (Non Open Market) 5,687 n/a
Jul 17, 2014 brown michael s Director Disposition (Non Open Market) 14,662 n/a
Dec 22, 2010 brown michael s Director Disposition (Non Open Market) 5,000 n/a
Dec 12, 2007 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Dec 17, 2007 gilman alfred g Director Disposition (Non Open Market) 1,500 n/a
Dec 19, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Dec 24, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Dec 19, 2008 gilman alfred g Director Disposition (Non Open Market) 1,000 n/a
Showing 361-380 of 887 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)